Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Surgery is Avoidable in Many Pneumothorax Cases

By HospiMedica International staff writers
Posted on 13 Feb 2020
A new study suggests that conservative management of primary spontaneous pneumothorax may be better than surgical intervention, with a lower risk of serious adverse events.

Researchers at Royal Perth Hospital (RPH; Australia), the University of Western Australia (UWA; Crawley, Australia), the Medical Research Institute of New Zealand (MRINZ; Wellington, New Zealand), and other institutions conducted a multi-center study in 316 patients with unilateral, moderate-to-large, primary spontaneous pneumothorax. More...
Patients were randomized to surgical intervention with a drainage tube (154 patients) or conservative-management (162 patients). The primary outcome was lung re-expansion within eight weeks.

The results showed that re-expansion within eight weeks occurred in 98.5% of patients that underwent interventional management, and in 94.4% of those who underwent conservative management. The risk for complications was lower in the conservative management group than in the surgical intervention group, and recurrence of pneumothorax was more frequent in the intervention group (16.8%) than in the conservative-management group (8.8%). Conservative management also resulted in a lower risk of serious adverse events. The study was published on January 29, 2020, in the New England Journal of Medicine (NEJM).

“Patients without tubes spent much less time in hospital and had fewer complications; on average, the tube patients spent six days in hospital, while the non-tube patients spent 1.6 days,” said study co-author Kyle Perrin, PhD, of the MRINZ. “The patients were able to go home and get on with their lives immediately rather than stick around in hospital. But the obvious other outcome is the significant cost savings to the health system.”

Primary spontaneous pneumothorax is an abnormal accumulation of air in the pleural space that can result in the partial or complete collapse of a lung. It is likely due to the formation of small sacs of air (blebs) in lung tissue that rupture, causing air to leak into the pleural space, creating pressure that is manifest as chest pain on the side of the collapsed lung and shortness of breath. Often, people who experience a primary spontaneous pneumothorax have no prior sign of illness; the blebs themselves typically do not cause any symptoms and are visible only on medical imaging. Affected individuals may have one to more than thirty blebs.

Related Links:
Royal Perth Hospital
University of Western Australia
Medical Research Institute of New Zealand



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.